Artículos por temáticas

Factors affecting the physical stability of peptide self-assembly in neurodegenerative disorders

Saikia J, Sarkar M, Ramakrishnan V.

Neuropeptides. 2025 Jun;111:102517. doi: 10.1016/j.npep.2025.102517. Epub 2025 Mar 13.

Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders

Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, Singh G, Iqbal D, Padmapriya G, Kumar S, Kedia N, Verma R, Kumar R, Sinha A, Dheepak B, Abomughaid MM, Jha NK.

Mol Neurobiol. 2025 Jun;62(6):7975-7997. doi: 10.1007/s12035-024-04654-y. Epub 2025 Feb 17.

Advances in flexible sensor monitoring technology for neurodegenerative diseases in the elderly

Zhu Z, Wang H, Zhang L, Zeng L, Gan L, Jia B.

Nanotechnology. 2025 Jun 6;36(24). doi: 10.1088/1361-6528/adddc5.

Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies

Abdelaziz AM.

Int Immunopharmacol. 2025 May 27;156:114692. doi: 10.1016/j.intimp.2025.114692. Epub 2025 Apr 22.

Comparative efficacy of non-pharmacological interventions for Parkinson's disease with constipation: a systematic review and network meta-analysis

Zhang P, Su X, Han X, Zhao D, Wang J, Yang Y, Ye H.

Front Neurol. 2025 Jun 2;16:1579556. doi: 10.3389/fneur.2025.1579556. eCollection 2025.

Updates on Motor Imagery and Action Observation in Parkinson's Disease Motor Rehabilitation: A Systematic Review and Meta-analysis

Pettenuzzo TSA, Estivalet KM, Cabeleira MEP, Lahude AB, Righi NC, Mendes LO, Cechetti F.

NeuroRehabilitation. 2025 Jun;56(4):438-450. doi: 10.1177/10538135251325459. Epub 2025 Jun 2.

Epigenetic Regulation in Neuroplasticity: Key to Understanding and Treating Neurological Diseases

Minal N, Nilesh W, Akanksha K.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2025 Jun 19;41:e20250011. doi: 10.62958/j.cjap.2025.011.

Comparative effects of deep brain stimulation in subthalamic nucleus and globus pallidus interna on verbal fluency and working memory in adult populations with parkinson's disease: A systematic review

Trotman H, Jelley B, Umla-Runge K.

Clin Park Relat Disord. 2025 Jun 9;13:100355. doi: 10.1016/j.prdoa.2025.100355. eCollection 2025.

Environmental fate, toxicity, and mitigation of 6PPD and 6PPD-Quinone: Current understanding and future directions

Yi J, Ruan J, Yu H, Wu B, Zhao J, Wang H, Chen R, Yang Q, Chen J, Sun D.

Environ Pollut. 2025 Jun 15;375:126352. doi: 10.1016/j.envpol.2025.126352. Epub 2025 Apr 30.

Recent Advances in Visual Dysfunction and Ocular Biomarkers in Neurological Disorders

Cheng J, Paracha SS, Agrawal S, Wu Z, Sung CH.

Eye Brain. 2025 Jun 14;17:49-67. doi: 10.2147/EB.S516393. eCollection 2025.

Motor fluctuations in Parkinson disease - a mini-review of emerging drugs

Gros P, Armengou Garcia L, Fox SH.

Expert Opin Emerg Drugs. 2025 Jun 16:1-12. doi: 10.1080/14728214.2025.2517582. Online ahead of print.

Predictors of Informal Caregiver Burden in Parkinson's Disease: A Systematic Review

Lesley R, Simpson J, Dale M, Eccles F, Lock S, Gunn S.

West J Nurs Res. 2025 Jun;47(6):524-543. doi: 10.1177/01939459251327968. Epub 2025 Mar 26.

Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy

Rademacher DJ, Exline JE, Foecking EM.

Biomedicines. 2025 Jun 7;13(6):1400. doi: 10.3390/biomedicines13061400.

Neural Metabolic Networks: Key Elements of Healthy Brain Function

Madrer N, Perera ND, Uccelli NA, Abbondanza A, Andersen JV, Carsana EV, Demmings MD, Fernandez RF, de Fragas MG, Gbadamosi I, Kulshrestha D, Lima-Filho RAS, Marian OC, Markussen KH, McGovern AJ, Neal

J Neurochem. 2025 Jun;169(6):e70084. doi: 10.1111/jnc.70084.

Therapeutic potential of MK2 kinase inhibition in pathogenesis of Parkinson's disease

Nanda A, Pandey SK, Singh RK.

Expert Opin Ther Targets. 2025 Jun;29(6):303-308. doi: 10.1080/14728222.2025.2500421. Epub 2025 May 4.